Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system

Pérez Fidalgo, JA; Roda, D; Roselló, S; Rodríguez-Braun, E; Cervantes, A.
Clin. transl. oncol. (Print) ; 11(12): 787-798, dic. 2009.
Artigo em Inglês | IBECS (Espanha) | ID: ibc-123866

Documentos relacionados

  1. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway.
  2. Development of small molecule inhibitors targeting RNA helicase DHX33 as anti-cancer agents.
  3. Determinants of cancer drug pricing and how to overcome the cancer premium.
  4. Microbes mediated immunogenic cell death in cancer immunotherapy.
  5. A Meta-analysis on the Effectiveness of Extracellular Vesicles as Nanosystems for Targeted Delivery of Anticancer Drugs.
  6. Chemotherapy Induces Cancer-Fighting B Cells.
  7. Synthesis of a Non-Symmetrical Disorazole C<sub>1</sub>-Analogue and Its Biological Activity.
  8. Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs.
  9. Virtual screening of potential anticancer drugs based on microbial products.
  10. Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review.